z-logo
Premium
Exogenous and endogenous ghrelin counteracts GLP‐1 action to stimulate cAMP signaling and insulin secretion in islet β‐cells
Author(s) -
Damdindorj Boldbaatar,
Dezaki Katsuya,
Kurashina Tomoyuki,
Sone Hideyuki,
Rita Rauza,
Kakei Masafumi,
Yada Toshihiko
Publication year - 2012
Publication title -
febs letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.593
H-Index - 257
eISSN - 1873-3468
pISSN - 0014-5793
DOI - 10.1016/j.febslet.2012.06.034
Subject(s) - ghrelin , medicine , endocrinology , forskolin , islet , insulin , endogeny , activator (genetics) , chemistry , pancreatic islets , receptor , downregulation and upregulation , biology , biochemistry , gene
We studied interactive effects of insulinotropic GLP‐1 and insulinostatic ghrelin on rat pancreatic islets. GLP‐1 potentiated glucose‐induced insulin release and cAMP production in isolated islets and [Ca 2+ ] i increases in single β‐cells, and these potentiations were attenuated by ghrelin. Ghrelin suppressed [Ca 2+ ] i responses to an adenylate cyclase activator forskolin. Moreover, GLP‐1‐induced insulin release and cAMP production were markedly enhanced by [ d ‐lys 3 ]‐GHRP‐6, a ghrelin receptor antagonist, in isolated islets. These results indicate that both exogenous and endogenous islet‐derived ghrelin counteracts glucose‐dependent GLP‐1 action to increase cAMP production, [Ca 2+ ] i and insulin release in islet β‐cells, positioning ghrelin as a modulator of insulinotropic GLP‐1.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom